MAIA Biotechnology (MAIA) Stock Price, News & Analysis

Company Overview

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $2.68 to $2.77
• 50-Day Range: N/A
• 52-Week Range: $0.82 to $5.99
• Volume: 38,203 shs
• Average Volume: 311,536 shs
• Market Capitalization: $64.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MAIA Biotechnology Stock Analysis - MarketRank™

MAIA Biotechnology scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for MAIA Biotechnology.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MAIA Biotechnology is -1.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of MAIA Biotechnology is -1.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

MAIA Biotechnology has a P/B Ratio of 89.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.15% of the float of MAIA Biotechnology has been sold short.

Short Interest Ratio / Days to Cover

MAIA Biotechnology has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in MAIA Biotechnology has recently decreased by 1.07%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MAIA Biotechnology does not currently pay a dividend.

Dividend Growth

MAIA Biotechnology does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.15% of the float of MAIA Biotechnology has been sold short.

Short Interest Ratio / Days to Cover

MAIA Biotechnology has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in MAIA Biotechnology has recently decreased by 1.07%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: N/A

News Sentiment

MAIA Biotechnology has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for MAIA Biotechnology this week, compared to 1 article on an average week.

Search Interest

1 people have searched for MAIA on MarketBeat in the last 30 days.

MarketBeat Follows

Only 2 people have added MAIA Biotechnology to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MAIA Biotechnology insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.98% of the stock of MAIA Biotechnology is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.65% of the stock of MAIA Biotechnology is held by institutions.

MAIA Stock Analysis - Frequently Asked Questions

How have MAIA shares performed this year?

MAIA Biotechnology's stock was trading at $3.04 at the beginning of the year. Since then, MAIA stock has decreased by 11.8% and is now trading at $2.68.
View the best growth stocks for 2024 here.

How were MAIA Biotechnology's earnings last quarter?

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) posted its quarterly earnings data on Friday, August, 9th. The company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.16.

How do I buy shares of MAIA Biotechnology?

Shares of MAIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/09/2024
• Today: 10/02/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSEAMERICAN:MAIA
• CUSIP: N/A
• CIK: N/A
• Web: www.MAIABiotech.com
• Phone: 312-416-8592
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-19,770,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -14,708.83%
• Return on Assets: -259.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.42
• Quick Ratio: 3.42

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.03 per share
• Price / Book: 89.33

Miscellaneous

• Outstanding Shares: 23,910,000
• Free Float: 13,762,000
• Market Cap: $64.08 million
• Optionable: Not Optionable
• Beta: 0.33